ProfileGDS4132 / 213004_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 64% 58% 68% 65% 74% 77% 75% 70% 69% 67% 75% 72% 76% 67% 82% 75% 75% 85% 79% 61% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101183.67764
GSM201543Muscle PCOS pioglitazone 121152.44258
GSM201544Muscle PCOS pioglitazone 161202.85368
GSM201545Muscle PCOS pioglitazone 201196.57565
GSM201829Muscle PCOS pioglitazone 231244.774
GSM201830Muscle PCOS pioglitazon 251254.74777
GSM201831Muscle PCOS pioglitazone 271242.57375
GSM201832Muscle PCOS pioglitazone 31202.48670
GSM201833Muscle PCOS pioglitazone 41192.66569
GSM201834Muscle PCOS pioglitazone 81196.05167
GSM201835Muscle PCOS after pioglitazone 102237.85875
GSM201836Muscle PCOS after pioglitazone 122216.0872
GSM201837Muscle PCOS after pioglitazone 162226.58776
GSM201838Muscle PCOS after pioglitazone 202190.35367
GSM201839Muscle PCOS after pioglitazone 232302.58982
GSM201840Muscle PCOS after pioglitazone 252243.86375
GSM201841Muscle PCOS after pioglitazone 272230.95975
GSM201842Muscle PCOS after pioglitazone 32310.61985
GSM201843Muscle PCOS after pioglitazone 42270.91379
GSM201844Muscle PCOS after pioglitazone 82173.06661